Akari Therapeutics Plc (AKTX) SEC filings and CIK.
AKTX’s SEC Central Index Key (CIK) is 0001541157, or 1541157 without leading zeros. The SEC’s ticker file lists it as Akari Therapeutics Plc.
- Ticker
- AKTX
- CIK
- 0001541157
- Other tickers
- None
- Insider transactions, Q3 2026
- 5
Insider trading
In Q3 2026, insiders at Akari Therapeutics Plc reported 5 non-derivative transactions on 3 Forms 3, 4 and 5, including 0 open-market purchases and 0 sales. See every AKTX insider transaction →
Recent filings we observed
No filings for this CIK appear in our current observation window. The full history is available from the filings endpoint below and on SEC.gov.
Form D offerings
| Filed | Type | Amount sold | Industry |
|---|---|---|---|
| 2026-06-03 | D | $1.8M | Other Health Care |
Get AKTX SEC data through the API
curl "https://sec-api.dev/api/v1/filings?cik=1541157&limit=10" \
-H "Authorization: Bearer $SEC_API_KEY"curl "https://sec-api.dev/api/v1/companies/1541157" \
-H "Authorization: Bearer $SEC_API_KEY"curl "https://sec-api.dev/api/v1/facts/1541157?taxonomy=us-gaap&concept=Revenues&limit=10" \
-H "Authorization: Bearer $SEC_API_KEY"Ticker to CIK API · SEC filings API · Akari Therapeutics Plc on SEC.gov
Questions
What is AKTX’s CIK number?
AKTX’s SEC Central Index Key (CIK) is 0001541157, or 1541157 without leading zeros. The SEC’s ticker file lists it as Akari Therapeutics Plc.
How do I find Akari Therapeutics Plc’s 10-K?
Request /api/v1/filings?cik=1541157&form=10-K, or open the company’s EDGAR page and filter by 10-K. Foreign issuers file 20-F or 40-F instead.
Plain-text version for agents and LLMs: /companies/aktx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.